InKine Visicol

Sodium phosphate tablets for cleansing of the bowel as a preparation for colonoscopy approved by FDA Sept. 21. InKine filed NDA 21-097 on Nov. 23 under the name Diacol. The name was changed to Visicol after FDA determined Diacol was too similar to Watson's calcium channel blocker Dilacor

More from Archive

More from Pink Sheet